References
- Whitbread AK, Masoumi A, Tetlow N, et al. Characterization of the omega class of glutathione transferases. Methods Enzymol. 2005;401:78–99.
- Simic T, Savic-Radojevic A, Pljesa-Ercegovac M, et al. Glutathione S-transferases in kidney and urinary bladder tumors. Nat Rev Urol. 2009;6:281–289.
- Tew KD, Manevich Y, Grek C, et al. The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radic Biol Med. 2011;51:299–313.
- Tew KD, Townsend DM. Redox platforms in cancer drug discovery and development. Curr Opin Chem Biol. 2011;15:156–161.
- Savic-Radojevic A, Mimic-Oka J, Pljesa-Ercegovac M, et al. Glutathione S-transferase-P1 expression correlates with increased antioxidant capacity in transitional cell carcinoma of the urinary bladder. Eur Urol. 2007;52:470–477.
- Menon D, Board PG. A role for glutathione transferase Omega 1 (GSTO1-1) in the glutathionylation cycle. J Biol Chem. 2013;288:25769–25779.
- Djukic TI, Savic-Radojevic AR, Pekmezovic TD, et al. Glutathione S-transferase T1, O1 and O2 polymorphisms are associated with survival in muscle invasive bladder cancer patients. PLoS One. 2013;8:e74724.
- Piaggi S, Raggi C, Corti A, et al. Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity. Carcinogenesis. 2010;31:804–811.
- Eble JN, Sauter G, Epstein JI, et al., editors. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004.
- Babjuk M, Burger M, Zigeuner R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013;64:639–653.
- Witjes JA, Compérat E, Cowan NC, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65:778–792.
- Simic T, Mimic-Oka J, Savic-Radojevic A, et al. Glutathione S-transferase T1-1 activity upregulated in transitional cell carcinoma of urinary bladder. Urology. 2005;65:1035–1040.
- Ravindranath V. Animal models and molecular markers for cerebral ischemia-reperfusion injury in brain. Methods Enzymol. 1994;233:610–619.
- Holmgren A, Aslund F. Glutaredoxin. Methods Enzymol. 1995;252:283–292.
- Yusuf MA, Chuang T, Bhat GJ, et al. Cys-141 glutathionylation of human p53: studies using specific polyclonal antibodies in cancer samples and cell lines. Free Radic Biol Med. 2010;49:908–917.
- Gallogly MM, Starke DW, Mieyal JJ. Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation. Antioxid Redox Signal. 2009;11:1059–1081.
- Cha M-K, Kim I-H. Preferential overexpression of glutaredoxin3 in human colon and lung carcinoma. Cancer Epidemiol. 2009;33:281–287.
- Berendsen CL, Mulder TP, Peters WH. Plasma glutathione S-transferase pi 1-1 AND alpha 1-1 levels in patients with bladder cancer. J Urol. 2000;164:2126–2128.
- Pljesa-Ercegovac M, Savic-Radojevic A, Kravic-Stevovic T, et al. Co-localization of GSTP1 and JNK in transitional cell carcinoma of urinary bladder. Genet Mol Biol. 2010;33:460–462.
- Board PG, Menon D. Glutathione transferases, regulators of cellular metabolism and physiology. Biochim Biophys Acta. 2013;1830:3267–3288.
- Zhang J, Grek C, Ye Z-W, et al. Pleiotropic functions of glutathione S-transferase P. Adv Cancer Res. 2014;122:143–175.
- Li Y, Zhang Q, Peng B, et al. Identification of glutathione S-transferase omega 1 (GSTO1) protein as a novel tumor-associated antigen and its autoantibody in human esophageal squamous cell carcinoma. Tumour Biol. 2014;35:10871–10877.
- Piaggi S, Marchi S, Ciancia E, et al. Nuclear translocation of glutathione transferase omega is a progression marker in Barrett’s esophagus. Oncol Rep. 2009;21:283–287.
- Gómez-Ruiz S, Maksimović-Ivanić D, Mijatović S, et al. On the discovery, biological effects, and use of cisplatin and metallocenes in anticancer chemotherapy. Bioinorg Chem Appl. 2012;2012:1–14.
- Ramkumar K, Samanta S, Kyani A, et al. Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor. Nat Commun. 2016;7:13084.